front

Study demonstrates effective treatment option for FIP in cats in NZ

Not very long ago, feline infectious peritonitis (FIP) was considered invariably fatal in cats, but an antiviral drug called Remdesivir became widely available during the Covid pandemic and provided a promising treatment option. Results of a recent study by Dr Kelsey Renner, funded by Healthy Pets, are available now and provide valuable information on the effectiveness of remdesivir given orally in cases in New Zealand.

Findings on cardiomyopathy in NZ cats study just released

Cardiomyopathy is a primary myocardial disorder that changes the structure and function of the heart muscle in the absence of other disease sufficient to cause the observed myocardial abnormality. Until Dr Joon Seo’s recently completed research, there were no studies evaluating the prevalence of cardiomyopathy in cats in New Zealand. However, studies of cats in the UK and USA suggest that approximately 15% of clinically healthy cats in the general population have cardiomyopathy that is detectable using echocardiography.

Can we do better with our dog interactions?

The latest study to be funded under the Human-Animal Bond grant seeks to understand what constitutes a positive experience for the dogs when it comes to dog-handler interactions by measuring their oxytocin levels during various interactions. Hopefully this will help educate anyone interacting with dogs, including owners, on how we can do better and reduce the incidence of behavioural disorders.